Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...

It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes ...

PsA can be challenging, but these expert-approved tips for reframing how you think, talk, and feel about your condition can ...

Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across ...

Another potential cause of brain fog: “If you have an autoimmune disease such as psoriatic arthritis, you’re more likely to have fibromyalgia,” says Anca Askanase, MD, a professor of ...

The pharma began its outreach to the HS community well before securing Bimzelx’s approval in the indication. In the spring of ...

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

Certolizumab Pegol is indicated for the treatment of patients with rheumatoid arthritis, polyarticular juvenile idiopathic ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...

Lupin & Zentiva ink licensing and supply agreement for commercializing biosimilar Certolizumab Pegol: Our Bureau, Mumbai Wednesday, July 9, 2025, 16:20 Hrs [IST] Global Pharma maj ...

Psoriatic arthritis (PsA) is a chronic inflammatory condition that may cause pain and disability. It may be managed with medication and lifestyle changes. While PsA isn’t life threatening ...